D-amino Acid Oxidase Inhibition (DAAOI-1) add-on Treatment for Chronic Schizophrenia

NCT00960219 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenias
Psychoses
Psychotic Disorders
Schizophrenic Disorders

Interventions

DRUG: D-amino acid oxidase inhibition (DAAOI-1)
DRUG: placebo

Sponsor

China Medical University Hospital